We Announce our Role as Advisor to Sagard NewGen

Events October 6, 2022

The MedTech Conference 2022

We are pleased to share that we will be joining the MedTech Conference 2022 as sponsors and speakers! This year’s edition will have more than 100 sessions focusing on today’s hot topics.

M&A MedTech Regulatory

News January 13, 2022

Alira Health Secures an Additional $40M in Funding, Led by Creadev

We announced today the closing of an equity financing in which it raised gross proceeds of US$40 million. We intend to use the funds to invest in solutions that actively engage patients(...)

M&A MedTech Pharma

Publications August 3, 2021

What You Should Know Before Choosing a Healthcare Transaction Advisory Firm

What’s most important when selecting a firm for your next transaction? Global experience, staff profiles, technical expertise? To learn more read our latest TAD Infographic.

M&A

News April 12, 2021

Alira Health Strengthens Growth Strategy with $35M Funding, led by Creadev

Alira Health strengthens its growth strategy with a $35M funding, led by Creadev.

M&A MedTech Pharma

News December 20, 2020

We Announce our role as Strategic Advisor to Mérieux Equity Partners and Mérieux Participations 3 for Entering the Capital of CTRS

We are pleased to announce our role as strategic advisor to Mérieux Equity Partners as they join the Series A financing round of Cell-Easy, through Mérieux’s newly established venture fund, OMX.

M&A Pharma

News November 29, 2020

Alira Health as Strategic Advisor to Benvic in Acquisition Luc & Bel

We are proud to announce our role as strategic advisor to Benvic in the acquisition of Luc & Bel.

CDMO M&A

Publications November 1, 2020

Five Key Success Factors for Managing Transactions in Full Virtual Mode

It is no secret that the COVID-19 pandemic has presented new challenges for businesses, and virtual has become the ‘new normal’, including for transactions.

M&A